Suppr超能文献

使用神经肌肉阻滞剂和新斯的明进行全身麻醉及其与神经轴阻滞的关联:一项回顾性研究。

Use of neuromuscular blockers and neostigmine for general anesthesia and its association with neuraxial blockade: A retrospective study.

作者信息

Santos Filipe Nadir Caparica, Braga Angélica de Fátima de Assunção, Junqueira Fernando Eduardo Feres, Bezerra Rafaela Menezes, Almeida Felipe Ferreira de, Braga Franklin Sarmento da Silva, Carvalho Vanessa Henriques

机构信息

Department of Anesthesiology Department of Pharmacology, State University of Campinas, Rua Tessália Vieira de Camargo, 126 - Cidade Universitária Zeferino Vaz, Campinas, SP, Brazil - CEP 13083-887.

出版信息

Medicine (Baltimore). 2017 Jun;96(26):e7322. doi: 10.1097/MD.0000000000007322.

Abstract

This research aimed to assess the use of neuromuscular blockers (NMB) and its reversal, associated or not with neuraxial blockade, after general anesthesia.This retrospective study analyzed 1295 patients that underwent surgery with general anesthesia at Prof. Dr. José Aristodemo Pinotti Hospital in 2013. The study included patients aged >1 year, with complete, readable medical charts and anesthetic records.Rocuronium (ROC) was the most used NMB (96.7%), with an initial dose of 0.60 (0.52-0.74) mg/kg and total dose of 0.38 (0.27-0.53) mg/kg/h. In 24.3% of the cases, neuraxial blockade was associated with a significantly longer anesthesia (P < .001) than in cases without neuraxial block, regardless of technique (total intravenous (TIV) vs intravenous and inhalational (IV+IN)). In 71.9% of the cases, a single dose of NMB was used. Patients under TIV general anesthesia associated with neuraxial blockade had a lower total dose of ROC (mg/kg/h) in comparison with TIV GA alone (0.30 (0.23-0.39) and 0.42 (0.30-0.56) mg/kg/h, respectively, P < .001). The same was observed for patients under IV+IN GA (0.32 (0.23-0.41) and 0.43 (0.31-0.56) mg/kg/h, respectively, P < .001). The duration of anesthesia was longer according to increasing number of additional NMB doses (P < .001). Dose of neostigmine was 2.00 (2.00-2.00) mg or 29.41 (25.31-33.89) μg/kg. The interval between neostigmine and extubation was >30 minutes in 10.9% of cases.The most widely used NMB was ROC. Neuroaxial blockade (spinal or epidural) was significantly associated with reduced total dose of ROC (mg/kg/h) during general anesthesia, even in the absence of neuromuscular monitoring and regardless of general anesthetic technique chosen. In most cases, neostigmine was used to reverse neuromuscular block. The prolonged interval between neostigmine and extubation (>30 minutes) was neither associated with total doses of ROC or neostigmine, nor with the time of NMB administration. This study corroborates the important role of quantitative neuromuscular monitors and demonstrates that neuraxial blockade is associated with reduced total ROC dose. Further studies are needed to evaluate the possible role of neuraxial blockade in reducing the incidence of postoperative residual curarization.

摘要

本研究旨在评估全身麻醉后使用神经肌肉阻滞剂(NMB)及其逆转情况,无论是否联合使用神经轴阻滞。这项回顾性研究分析了2013年在若泽·阿里斯托德莫·皮诺蒂教授医院接受全身麻醉手术的1295例患者。该研究纳入年龄大于1岁、拥有完整且可读的病历和麻醉记录的患者。罗库溴铵(ROC)是最常用的NMB(96.7%),初始剂量为0.60(0.52 - 0.74)mg/kg,总剂量为0.38(0.27 - 0.53)mg/kg/h。在24.3%的病例中,无论采用何种技术(全静脉麻醉(TIV)与静脉和吸入麻醉(IV + IN)),神经轴阻滞与无神经轴阻滞的病例相比,麻醉时间显著更长(P <.001)。在71.9%的病例中,使用了单剂量的NMB。与单独的TIV全身麻醉相比,联合神经轴阻滞的TIV全身麻醉患者的ROC总剂量(mg/kg/h)更低(分别为0.30(0.23 - 0.39)和0.42(0.30 - 0.56)mg/kg/h,P <.001)。IV + IN全身麻醉的患者也观察到同样情况(分别为0.32(0.23 - 0.41)和0.43(0.31 - 0.56)mg/kg/h,P <.001)。随着额外NMB剂量的增加,麻醉持续时间更长(P <.001)。新斯的明剂量为2.00(2.00 - 2.00)mg或29.41(25.31 - 33.89)μg/kg。在10.9%的病例中,新斯的明与拔管之间的间隔时间超过30分钟。使用最广泛的NMB是ROC。神经轴阻滞(脊髓或硬膜外)与全身麻醉期间ROC总剂量(mg/kg/h)降低显著相关,即使在没有神经肌肉监测且无论选择何种全身麻醉技术的情况下也是如此。在大多数情况下,使用新斯的明来逆转神经肌肉阻滞。新斯的明与拔管之间延长的间隔时间(>30分钟)既与ROC或新斯的明的总剂量无关,也与NMB给药时间无关。本研究证实了定量神经肌肉监测仪的重要作用,并表明神经轴阻滞与ROC总剂量降低相关。需要进一步研究来评估神经轴阻滞在降低术后残余肌松发生率方面的可能作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53c/5500064/8cc64182720d/medi-96-e7322-g002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验